| P2093 | author name string | Eleftherios P Diamandis | |
| | Ioannis Prassas | |
| | Victoria Higgins | |
| | Dorsa Sohaei | |
| P2860 | cites work | Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management | Q102221428 |
| | The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. | Q48853544 |
| | Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. | Q51859209 |
| | Laryngeal Injury and Upper Airway Symptoms After Oral Endotracheal Intubation With Mechanical Ventilation During Critical Care: A Systematic Review | Q57170029 |
| | Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection | Q64133854 |
| | Exercise capacity and pulmonary function in hospital workers recovered from severe acute respiratory syndrome | Q80230323 |
| | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Q83767469 |
| | The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation | Q83926320 |
| | CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus | Q24307914 |
| | One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. | Q30362578 |
| | A major outbreak of severe acute respiratory syndrome in Hong Kong | Q33347382 |
| | Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. | Q33348618 |
| | Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study | Q33409373 |
| | Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature | Q33432598 |
| | Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study | Q33854901 |
| | Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome | Q34166102 |
| | Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference | Q34219343 |
| | SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases | Q34295383 |
| | Long-term cognitive impairment after critical illness | Q34374900 |
| | Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts | Q34396455 |
| | Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration | Q34463760 |
| | Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors | Q35564222 |
| | Possible central nervous system infection by SARS coronavirus | Q35879760 |
| | Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) | Q35905508 |
| | Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease | Q36394783 |
| | Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description | Q36807417 |
| | Cardiovascular complications of severe acute respiratory syndrome. | Q37000809 |
| | Physical complications in acute lung injury survivors: a two-year longitudinal prospective study | Q37646839 |
| | A cluster of cases of severe acute respiratory syndrome in Hong Kong. | Q37869740 |
| | Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology | Q39279748 |
| | Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. | Q40083785 |
| | Neurological Complications during Treatment of Middle East Respiratory Syndrome | Q40106479 |
| | Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). | Q40473391 |
| | Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. | Q40516274 |
| | Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection | Q40549271 |
| | Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study | Q40557821 |
| | Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. | Q40559650 |
| | Middle East Respiratory Syndrome Virus Pathogenesis | Q40590052 |
| | Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus | Q40774921 |
| | Follow-up chest radiographic findings in patients with MERS-CoV after recovery. | Q43191540 |
| | Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study | Q44592762 |
| | Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes | Q46068140 |
| | Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study | Q46550040 |
| | Psychiatric symptoms after acute respiratory distress syndrome: a 5-year longitudinal study | Q47560502 |
| | Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). | Q47693062 |
| | Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China | Q84574466 |
| | Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study | Q87191917 |
| | Pathological findings of COVID-19 associated with acute respiratory distress syndrome | Q87281430 |
| | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Q87412594 |
| | Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China | Q87759574 |
| | The association of mid-to late-life systemic inflammation with white matter structure in older adults: The Atherosclerosis Risk in Communities Study | Q88494021 |
| | Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission | Q89490397 |
| | Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China | Q89606309 |
| | Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia | Q89774758 |
| | Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study | Q89916821 |
| | Clinical Characteristics of Coronavirus Disease 2019 in China | Q89934806 |
| | Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study | Q90015815 |
| | Evidence for Gastrointestinal Infection of SARS-CoV-2 | Q90110784 |
| | Liver injury in COVID-19: management and challenges | Q90127043 |
| | Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis | Q90127409 |
| | Dysregulation of immune response in patients with COVID-19 in Wuhan, China | Q90251434 |
| | Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China | Q90296811 |
| | Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection | Q90320056 |
| | Prominent changes in blood coagulation of patients with SARS-CoV-2 infection | Q90330005 |
| | Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis | Q90366406 |
| | Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State | Q90455461 |
| | COVID-19: consider cytokine storm syndromes and immunosuppression | Q90464964 |
| | Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China | Q90646484 |
| | Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms | Q90660125 |
| | Chest X-ray findings in asymptomatic and minimally symptomatic quarantined patients in Codogno, Italy | Q90683091 |
| | Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China | Q90683895 |
| | Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study | Q90688501 |
| | Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) | Q90701689 |
| | Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) | Q90701695 |
| | Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV | Q90713511 |
| | Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission | Q90723898 |
| | Return to work after critical illness: a systematic review and meta-analysis | Q91197500 |
| | Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms | Q91257578 |
| | Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis | Q91529077 |
| | Pancreatic injury patterns in patients with COVID-19 pneumonia | Q91562969 |
| | Kidney disease is associated with in-hospital death of patients with COVID-19 | Q91567279 |
| | Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia | Q91765327 |
| | Hematological findings and complications of COVID-19 | Q91862441 |
| | Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis | Q91891256 |
| | Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study | Q91898135 |
| | Incidence of thrombotic complications in critically ill ICU patients with COVID-19 | Q91931008 |
| | Neurologic Features in Severe SARS-CoV-2 Infection | Q91957408 |
| | COVID-19 Presenting as Acute Hepatitis | Q92011949 |
| | Clinical Characteristics of Covid-19 in New York City | Q92014337 |
| | Guillain-Barré Syndrome Associated with SARS-CoV-2 | Q92014375 |
| | Fatigue Symptoms during the First Year after ARDS | Q92033063 |
| | The differential psychological distress of populations affected by the COVID-19 pandemic | Q92033824 |
| | COVID-19 and Racial Disparities | Q92037810 |
| | Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past | Q92040618 |
| | D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 | Q92045162 |
| | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | Q92081837 |
| | Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area | Q93147595 |
| | High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients | Q93152055 |
| | Endothelial cell infection and endotheliitis in COVID-19 | Q93180821 |
| | A rampage through the body | Q93195268 |
| | Survivors' burden | Q93195273 |
| | The pivotal link between ACE2 deficiency and SARS-CoV-2 infection | Q93237239 |
| | Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young | Q93339359 |
| | COVID-19 and its implications for thrombosis and anticoagulation | Q94295637 |
| | COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options | Q94467004 |
| | Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy | Q94470155 |
| | COVID-19 presenting as stroke | Q94491285 |
| | Follow-up studies in COVID-19 recovered patients - is it mandatory? | Q94493398 |
| | High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study | Q94522437 |
| | Assay Techniques and Test Development for COVID-19 Diagnosis | Q94554692 |
| | Racial Health Disparities and Covid-19 - Caution and Context | Q94571654 |
| | Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members | Q94588095 |
| | Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan | Q94931541 |
| | COVID-19 update: Covid-19-associated coagulopathy | Q94949420 |
| | ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19 | Q94950731 |
| | Pulmonary fibrosis secondary to COVID-19: a call to arms? | Q95293137 |
| | Cutaneous Manifestations of COVID-19: A Preliminary Review | Q95293753 |
| | Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 | Q95294644 |
| | Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review | Q95298763 |
| | Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study | Q95635380 |
| | COVID-19 presenting as acute pancreatitis | Q95658367 |
| | Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study | Q95659103 |
| | Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic | Q95936888 |
| | Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) | Q95941785 |
| | Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans | Q96026529 |
| | Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research | Q96028621 |
| | Lipase Elevation in Patients With COVID-19 | Q96117296 |
| | Thousands of people will help scientists to track the long-term health effects of the coronavirus crisis | Q96127970 |
| | Immediate and long-term consequences of COVID-19 infections for the development of neurological disease | Q96130910 |
| | Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities | Q96235014 |
| | Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections | Q96577059 |
| | CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells | Q96823951 |
| | COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon | Q96952038 |
| | The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings | Q97426603 |
| | Extrapulmonary manifestations of COVID-19 | Q97531770 |
| | The laboratory's role in combating COVID-19 | Q97541674 |
| | Persistent Symptoms in Patients After Acute COVID-19 | Q97558381 |
| | Survivorship after COVID-19 ICU stay | Q97568951 |
| | Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) | Q98170820 |
| | Into the looking glass: Post-viral syndrome post COVID-19 | Q98217392 |
| | Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis | Q98292905 |
| | Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach | Q98504821 |
| | Covid-19 acute responses and possible long term consequences: What nanotoxicology can teach us | Q98657025 |
| | Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case | Q98939607 |
| | Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children | Q99372551 |
| | Multisystem inflammatory syndrome in children: A systematic review | Q99408933 |
| | The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 | Q99614247 |
| | Age-specific COVID-19 case-fatality rate: no evidence of changes over time | Q99728397 |
| P921 | main subject | long covid | Q100732653 |
| | COVID-19 | Q84263196 |
| P304 | page(s) | 1-23 | |
| P577 | publication date | 2020-12-21 | |
| P1433 | published in | Critical Reviews in Clinical Laboratory Sciences | Q5186664 |
| P1476 | title | COVID-19: from3 an acute to chronic disease? Potential long-term health consequences | |